CAROLINA NÖR
Graduated in Pharmacy from UFRGS (2004) with qualifications in industrial pharmacy (2006) and master's degree in Pharmaceutical Sciences from UFRGS (2006). She worked in the pharmaceutical industry as a researcher developing new products at the company Cristália Produtos Químicos Farmacêuticos LTDA (2006 - 2008). Has experience in implementing and conducting drug stability studies. He holds a doctorate from the Postgraduate Program in Cellular and Molecular Biology at UFRGS (2013), with a sandwich internship at the University of Michigan (2011-2012). He has experience in the search for molecules with antitumor activity, based on in vitro studies, cellular and molecular biology, and in vivo, manipulation of immunocompromised animals.
Check the activity agenda
Monday, March 23, 2024
• Room 3
13:30-15:30
SESSION 4: PRESENT - FUTURE
Is proton beam therapy a real deal in pediatric neurooncology?
Pre-clinical studies in medulloblastoma: what is new?
Genetic Predisposition Syndromes: How new molecular technologies can help us in the diagnosis and treatment
When does Precision Medicine make a difference in the treatment of our pediatric patients with brain tumors?
The Medulloblastoma initiative-
Liquid biopsy for pediatric neurooncology tumors. Is it possible?
Study Protocol and Perspectives: Embryonal Tumors in infants
Discussion
Moderator: Gabriela Bellas (RJ)
Moderator: Maria Luisa Sucharski Figueiredo (Brasil)
Is proton beam therapy a real deal in pediatric neurooncology?
Speaker: Michael Jenwei Chen (SP)
Pre-clinical studies in medulloblastoma: what is new?
Speaker: Carolina Nör (Estados Unidos)
Genetic Predisposition Syndromes: How new molecular technologies can help us in the diagnosis and treatment
Speaker: Fernanda Teresa de Lima (SP)
When does Precision Medicine make a difference in the treatment of our pediatric patients with brain tumors?
Speaker: Elvis Terci Valera (SP)
The Medulloblastoma initiative-
Speaker: Fernando Goldsztein (RS)
Liquid biopsy for pediatric neurooncology tumors. Is it possible?
Speaker: Liana Figueiredo Nobre (Canadá)
Study Protocol and Perspectives: Embryonal Tumors in infants
Speaker: Natália Dassi (SP)
Discussion
Promoted by
Organization
Tourism agency
SILVER SPONSOR
BRONZE SPONSOR
SUPPORT SPONSOR
Institutional Support
